Prof Santiago Gonzalez-Moreno
Medical Director, Professor of Surgery
MD Anderson Cancer CentreSpain
Dr. González-Moreno is the Medical Director at Centro Oncológico MD Anderson International España in Madrid, Spain.
Dr. González-Moreno, born in Segovia, Spain on May 31 1968, is married and has 3 children. He completed his general surgery residency in Hospital Universitario “12 de Octubre” (Madrid). He continued his training in gastrointestinal surgical oncology as a clinical fellow for two years under Dr. Paul H. Sugarbaker at the Washington Cancer Institute in Washington, DC (USA), where he focused in peritoneal surface malignancy. Upon returning to Spain in 2001 he was commissioned to organize the surgical oncology practice at the newly created MD Anderson Cancer Center´s affiliation in Madrid, Spain where he has developed most of his career.
He received a PhD (cum laude) in appendiceal malignancy at University of Navarra in 2003 and was a Visiting Assistant Professor at the Department of Surgical Oncology in MD Anderson Cancer Center in Houston in 2005. He earned the European Board of Surgery Qualification in Surgical Oncology in 2004. He serves as editorial consultant and reviewer for several oncology scientific journals.
Dr. González-Moreno´s areas of research interest include colorectal, appendix and gastric cancer, peritoneal malignancy and intraperitoneal chemotherapy, abdominopelvic sarcomas and education. He has lectured throughout Spain, Europe and South America on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis, having published articles in peer-reviewed journals, edited books and organized national and international scientific meetings on this topic. He is among the founding members of the Spanish Peritoneal Surgical Oncology Group (GECOP). Among other commitments, he is the President of the Spanish Society of Surgical Oncology and is the Vicepresident of the Spanish Federation of Oncological Societies since 2008. He joined the Executive Committee of the European Society of Surgical Oncology in 2008 and is currently President of the Society (2016-2018).
His present focus of research is in peritoneal carcinomatosis of gastric origin.